OSLO, Norway, Nov. 5, 2013 (GLOBE NEWSWIRE) --
Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that members of
its executive management team will participate in the following upcoming
investor conferences:
Credit Suisse Healthcare Conference 2013
Date: 12-14 November 2013
Participants:
Jeff Albers (President, Algeta US)
Mike Booth (SVP, Communications)
Venue: Scottsdale, AZ, USA
DNB Markets Health Care Conference
Date: 27 November 2013
Participants:
Andrew Kay (President & CEO)
Thomas Ramdahl (Executive VP and COO)
Venue: Oslo, Norway
Deutsche Bank dbAccess Pharmaceutical Corporate Day
Date: 5 December 2013
Participants:
Andrew Kay (President & CEO)
Mike Booth (SVP, Communications)
Venue: London, UK
SEB Securities Best of Norway Day
Date: 12 December 2013
Participants:
Mike Booth (SVP, Communications)
Venue: New York, NY, USA
Presentations, where applicable, will be available to download at www.algeta.com
following these events.
###
For further information, please contact:
Mike Booth +1 646 410 1884
Communications & Corporate Affairs ir@algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson mark.swallow@citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton knut.ekern@hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications kwatson@macbiocom.com
Investor enquiries:
Tricia Truehart +1 646 378 2953
The Trout Group ttruehart@troutgroup.com
About Algeta
Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.
Press release: http://hugin.info/134655/R/1740508/584543.pdf
[HUG#1740508]